BioTelemetry, Inc.
(NASDAQ : BEAT)

( )
BEAT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABMDABIOMED, Inc.
-2.51%427.293.3%$598.54m
ISRGIntuitive Surgical, Inc.
-0.80%483.212.4%$420.67m
MDTMedtronic PLC
0.58%86.800.6%$414.41m
ALGNAlign Technology, Inc.
-1.76%353.276.3%$350.51m
SYKStryker Corporation
1.28%171.991.3%$342.59m
BSXBoston Scientific Corporation
1.49%32.631.1%$323.32m
ABTAbbott Laboratories
0.28%61.920.8%$312.94m
BDXBecton, Dickinson and Company
1.85%237.561.1%$282.08m
TMOThermo Fisher Scientific Inc.
1.09%208.781.0%$258.62m
BAXBaxter International Inc.
0.79%74.321.7%$239.57m
EWEdwards Lifesciences Corporation
0.41%152.801.2%$200.43m
COOCooper Companies, Inc.
1.39%237.242.2%$134.05m
XRAYDENTSPLY International Inc.
0.85%44.953.0%$132.85m
WATWaters Corporation
0.37%193.713.4%$132.79m
ZBHZimmer Biomet Holdings, Inc.
0.20%111.731.7%$105.21m

Company Profile

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The company also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through operates through three segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.